AIDS-Related Malignancies.
The changing face of the AIDS epidemic since the introduction of protease inhibitors has had a significant impact on AIDS-related malignancies. These issues, emerging concepts regarding pathophysiology and current treatment strategies, are the subject of this review.
Scadden
DT
AIDS Oncology Center, Massachusetts General Hospital, Dana-Farber/Partners Cancer Center, Harvard Medical School, Boston, Massachusetts, 02129, USA. scadden.david@mgh.harvard.edu
Howard
WW